Aseptic Meningitis Following Second Dose of an mRNA Coronavirus Disease 2019 Vaccine in a Healthy Male: Case Report and Literature Review
3
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Vaccines are one of the most important strategies against pandemics or epidemics involving infectious diseases. With the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there have been global efforts for rapid development of coronavirus disease 2019 (COVID-19) vaccine and vaccination is being performed globally on a massive scale. With rapid increase in vaccination, rare adverse events have been reported. Well-known neurological adverse events associated with COVID-19 vaccination include Guillain–Barré syndrome, myelitis, and encephalitis. However, COVID-19 vaccine-related aseptic meningitis has rarely been reported. A 32-year-old healthy man visited our hospital with a complaint of headache for 1 week. He had received the second dose of the BNT162b2 mRNA COVID-19 vaccine 2 weeks before the onset of headache. Since the initial cerebrospinal fluid (CSF) profile suggested viral meningitis, we started treatment with an antiviral agent. However, the symptoms and follow-up CSF profile on day 7 of hospitalization showed no improvement and SARS-CoV-2 IgG antibodies were detected in the CSF. We suspected aseptic meningitis associated with the vaccination and intravenous methylprednisolone (500 mg/day) was administered for 3 days. The symptoms improved and the patient was discharged on day 12 of hospitalization.
Abstract
Vaccines are one of the most important strategies against pandemics or epidemics involving infectious diseases. With the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there have been global efforts for rapid development of coronavirus disease 2019 (COVID-19) vaccine and vaccination is being performed globally on a massive scale. With rapid increase in vaccination, rare adverse events have been reported. Well-known neurological adverse events associated with COVID-19 vaccination include Guillain–Barré syndrome, myelitis, and encephalitis. However, COVID-19 vaccine-related aseptic meningitis has rarely been reported. A 32-year-old healthy man visited our hospital with a complaint of headache for 1 week. He had received the second dose of the BNT162b2 mRNA COVID-19 vaccine 2 weeks before the onset of headache. Since the initial cerebrospinal fluid (CSF) profile suggested viral meningitis, we started treatment with an antiviral agent. However, the symptoms and follow-up CSF profile on day 7 of hospitalization showed no improvement and SARS-CoV-2 IgG antibodies were detected in the CSF. We suspected aseptic meningitis associated with the vaccination and intravenous methylprednisolone (500 mg/day) was administered for 3 days. The symptoms improved and the patient was discharged on day 12 of hospitalization.
참고문헌 (17)
- Wu F, "A new coronavirus associated with human respiratory disease in China", Nature, 579, pp.265~269 (2020)
- Baden LR, "Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine", N Engl J Med, 384, pp.403~416 (2021)
- Polack FP, "Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine", N Engl J Med, 383, pp.2603~2615 (2020)
- "Daily vaccination status by city and province"[URL]
- Thakur KT, "Neurologic safety monitoring of COVID-19 vaccines : Lessons from the past to inform the present", Neurology, 97, pp.767~775 (2021)
- Di Pietrantonj C, "Vaccines for measles, mumps, rubella, and varicella in children", Cochrane Database Syst Rev, 4, pp.CD004407~ (2020)
- Jorquera L A, "Aseptic meningitis due to mumps vaccine. Case report and review of the literature", Rev Chilena Infectol, 37, pp.769~774 (2020)
- González B, "Recurrent encephalitis following annual influenza vaccine. Case report", Rev Chilena Infectol, 33, pp.226~228 (2016)
- Dudley MZ, "The state of vaccine safety science : systematic reviews of the evidence", Lancet Infect Dis, 20, pp.e80~e89 (2020)
- Weiss SR, "Coronavirus pathogenesis", Adv Virus Res, 81, pp.85~164 (2011)
- Lv P, "COVID-19-associated meningoencephalitis : A care report and literature review", Exp Ther Med, 21, pp.362~ (2021)
- Gromova OA, "Direct and indirect neurological signs of COVID-19", Neurosci Behav Physiol, pp.1~11 (2021)
- Nuovo GJ, "Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1subunit of the spike protein", Ann Diagn Pathol, 51, pp.151682~ (2021)
- Jolles S, "Drug-induced aseptic meningitis : diagnosis and management", Drug Saf, 22, pp.215~226 (2000)
- Saito K, "Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine", Neurol Sci, 42, pp.4433~4435 (2021)
- Lee JK, "Aseptic meningitis following the second dose of comirnaty vaccination in an adolescent patient : A case report", Pediatr Infect Dis J, 41, pp.172~174 (2022)
- Chan AC, "Aseptic meningitis after BNT-162b2 COVID-19 vaccination", Brain Behav Immun Health, 19, pp.100406~ (2022)